Higher phospho-MAPK signaling was observed in the squamous cell carcinoma (Fig. 3h), consistent with the CBL mutation in the squamous cell carcinoma, though it could be driven by other mutations and/or microenvironmental factors. Here, CBL is linked to squamous cell carcinoma.